Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is blood or bone marrow better?

A Kessinger1

  • 1University of Nebraska Medical Center, Omaha 68198-3330.

Stem Cells (Dayton, Ohio)
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

High-dose therapy ablates hematopoiesis, but stem cell transplantation can restore it. Autologous peripheral stem cell transplantation (PSCT) and autologous bone marrow transplantation (ABMT) offer unique benefits for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.

Cytotherapy·2010
Same author

An ex vivo model of hematopoietic stem cell mobilization.

Cytotherapy·2005
Same author

Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.

Cytotherapy·2003
Same author

The impact of escalating regulatory requirements on the conduct of clinical research.

Cytotherapy·2003
Same author

Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4-9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation.

Bone marrow transplantation·2003
Same author

The whys and hows of hematopoietic progenitor and stem cell mobilization.

Bone marrow transplantation·2003
Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026
Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026
Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026
Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026
Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026
Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • High-dose radiation-chemotherapy ablates hematopoietic stem cells.
  • Hematopoietic stem cell transplantation is crucial for restoring blood cell production.
  • Autologous peripheral stem cell transplantation (PSCT) and autologous bone marrow transplantation (ABMT) are established methods.

Purpose of the Study:

  • To compare the characteristics and clinical utility of PSCT and ABMT.
  • To identify situations where one transplant type is preferable over the other.
  • To highlight potential advancements in both ABMT and PSCT.

Main Methods:

  • Review of clinical situations favoring PSCT or ABMT.
  • Discussion of stem cell collection, processing, and storage differences.

Related Experiment Videos

  • Exploration of mobilization techniques for peripheral stem cells.

    • Main Results:

    • Marrow metastases may preclude ABMT, making blood-derived stem cells a suitable alternative.
    • PSCT requires more time and labor for collection, processing, and storage.
    • Mobilization techniques can enhance peripheral autograft recovery of blood cell lineages.

    Conclusions:

    • The choice between PSCT and ABMT depends on specific clinical circumstances.
    • Peripheral stem cell mobilization may lead to faster hematologic recovery.
    • Continued advances in both ABMT and PSCT hold promise for improving patient outcomes.